Labesfal - Laboratórios Almiro


Global healthcare company supplying intravenous medicines and fluids, clinical nutrition (enteral and parenteral), medical technologies for infusion/transfusion/cell therapies, and biopharmaceuticals (including biosimilars and CDMO services). Operates a global R&D and manufacturing network with integrated quality, environmental and pharmacovigilance systems. The company is investing in digital health (device connectivity, interoperability, RFID traceability, patient and clinician applications) and sustainability measures (energy management and ISO-aligned environmental systems).

Industries

health-care
manufacturing
pharmaceutical

Nr. of Employees

small (1-50)

Labesfal - Laboratórios Almiro

Taguspark - Edifício Inovação I, 223/224, Av. Jacques Delors 3, 2740-122 Porto Salvo, Portugal


Products

Infusion pumps and disposable infusion sets

Programmable infusion and perfusion pumps plus a range of disposable sets and accessories for intravenous and enteral administration.

IV fluids and injectable medicines

Portfolio of intravenous fluids, electrolytes, colloids and injectable medicines supplied in multiple container formats for acute and chronic care.

Enteral and parenteral nutrition products

Oral nutritional supplements, enteral feeding formulas and parenteral nutrition solutions for clinical and home use.

Blood collection, apheresis and transfusion systems

Systems and specialized blood bag sets for whole blood collection, apheresis, plasma collection and autotransfusion.

Automated cell-processing laboratory systems

Laboratory-scale automated systems for cell washing, processing and preparation to support cell therapy workflows.

Biosimilar therapeutic medicines

Portfolio of biosimilar medicines for therapeutic areas including immunology and oncology.


Services

Contract development and manufacturing for biologics and biosimilars, including process development and commercial production.

Support programs for patients receiving home enteral or parenteral nutrition and for patients treated with biological therapies, including training and educational materials.

Development and integration of digital applications for clinicians and patients, RFID-based traceability systems and interoperability solutions between medical devices and hospital IT, with attention to cybersecurity.

Expertise Areas

  • Biosimilar development and commercialization
  • Biopharmaceutical CDMO services
  • Sterile IV drug and fluid manufacturing
  • Clinical nutrition formulation and home nutrition services
  • Show More (6)

Key Technologies

  • Cell-culture bioprocessing and protein purification
  • Sterile fill–finish for injectables and IV fluids
  • Infusion pump and perfusion system technologies
  • Apheresis and blood-collection systems
  • Show More (7)

News & Updates

ISO 9001 certification covering c.110 organizations including market units, compounding centers and production sites.

ISO 13485 certificate for medical device quality management (document referenced on certificates page).

Photovoltaic installation (4,540 panels) deployed at the Santiago de Besteiros industrial complex to supply roughly 20% of the site's electricity consumption.

Reported more than 41,000 employees and sales over EUR 8.4 billion (2024).

Company-stated metrics including a substantial installed base of infusion pumps and extensive use of blood-bag systems in donation programmes.

Anniversary of longstanding clinical nutrition portfolio and continued provision of enteral nutrition solutions.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.